Form 4: Orthofix Director Vickie L. Capps Reports Acquisition of Deferred Stock Units and Stock Options

Director Vickie L. Capps reports acquisition of deferred stock units and stock options in Orthofix Medical Inc.

Summary

• On March 11, 2025, Vickie L. Capps, a director of Orthofix Medical Inc., reported the acquisition of 3,093 shares of common stock and 35,270 employee stock options.
• The 3,093 shares represent an award of deferred stock units that vest in full on the earlier of June 30, 2025, or the date of the 2025 annual meeting of stockholders, contingent upon continued service.
• Each deferred stock unit represents a contingent right to receive one share of common stock, settling within 45 days of service termination.
• The 35,270 stock options have an exercise price of $17.1 and vest in four equal installments on the first, second, third, and fourth anniversary of the grant date, expiring on March 11, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which doesn't inherently suggest positive or negative implications.

Positives

• The acquisition of deferred stock units and stock options by a director signals confidence in the company's future performance.
• The vesting schedules for both the deferred stock units and stock options incentivize long-term commitment from the director.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be useful for investors assessing management's alignment with shareholder interests.

Stakeholder Impact

• Shareholders may view the acquisition of stock options and deferred stock units by a director as a positive sign, aligning management's interests with theirs.

Key Dates